Evidence map›Paper›PMID 31514417›Full record

ArticleMolecules (Basel, Switzerland)2019

Octadecaneuropeptide (ODN) Induces N2a Cells Differentiation through a PKA/PLC/PKC/MEK/ERK-Dependent Pathway: Incidence on Peroxisome, Mitochondria, and Lipid Profiles.

Amira Namsi, Thomas Nury, Amira S Khan, Jérôme Leprince, David Vaudry, Claudio Caccia, Valerio Leoni, Atanas G Atanasov, Marie-Christine Tonon, Olfa Masmoudi-Kouki and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Bioactive Molecules and Their Mechanisms of Action.Molecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 6 countries.

Amira NamsiTeam Bio-PeroxIL, Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism (EA7270)/University Bourgogne Franche-Comté (UBFC)/Inserm, 21000 Dijon, France. amira.namsi@gmail.com.
Thomas NuryTeam Bio-PeroxIL, Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism (EA7270)/University Bourgogne Franche-Comté (UBFC)/Inserm, 21000 Dijon, France. thomas.nury@u-bourgogne.fr.
Amira S KhanPhysiology of Nutrition & Toxicology (NUTox), Inserm U1231, University UBFC, 21000 Dijon, France. amira.khan@u-bourgogne.fr.
Jérôme LeprinceUNIROUEN, Inserm U1239, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation, Normandie University, 76000 Rouen, France. jerome.leprince@univ-rouen.fr.
David VaudryUNIROUEN, Inserm U1239, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation, Normandie University, 76000 Rouen, France. david.vaudry@univ-rouen.fr.
Claudio CacciaLaboratory of Medical Genetics and Neurogenetics, Foundation IRCCS Istituto Neurologico Carlo Besta, 20100 Milan, Italy. claudio.caccia@istituto-besta.it.
Valerio LeoniLaboratory of Clinical Chemistry, Hospital of Varese, ASST-Settelaghi, 20100 Milan, Italy. valerioleoni@hotmail.com.
Atanas G AtanasovInstitute of Genetics and Animal Breeding of the Polish Academy of Sciences, Jastrzebiec, 05-552 Magdalenka, Poland. atanas.atanasov@univie.ac.at.
Marie-Christine TononUNIROUEN, Inserm U1239, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation, Normandie University, 76000 Rouen, France. marie-christine.tonon@univ-rouen.fr.
Olfa Masmoudi-KoukiFaculty of Science of Tunis, University Tunis El Manar, LR18ES03, Laboratory of Neurophysiology, Cellular Physiopathology and Biomolecules Valorisation, Tunis 2092, Tunisia. olfa.masmoudi@fst.utm.tn.
Gérard LizardTeam Bio-PeroxIL, Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism (EA7270)/University Bourgogne Franche-Comté (UBFC)/Inserm, 21000 Dijon, France. gerard.lizard@u-bourgogne.fr.
Inserm · FRTunis University · TNFondazione IRCCS Istituto Neurologico Carlo Besta · ITUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative diseases are characterized by oxidative stress, mitochondrial damage, and death of neuronal cells. To counteract such damage and to favor neurogenesis, neurotrophic factors could be used as therapeutic agents. Octadecaneuropeptide (ODN), produced by astrocytes, is a potent neuroprotective agent. In N2a cells, we studied the ability of ODN to promote neuronal differentiation. This parameter was evaluated by phase contrast microscopy, staining with crystal violet, cresyl blue, and Sulforhodamine 101. The effect of ODN on cell viability and mitochondrial activity was determined with fluorescein diacetate and DiOC

Indexed as

AnimalsCell DifferentiationCell Line, TumorCell SurvivalCyclic AMP-Dependent Protein KinasesDiazepam Binding InhibitorLipidsMAP Kinase Signaling SystemMiceMitochondriaNeuropeptidesPeptide FragmentsPeroxisomesProtein Kinase CRhodaminesSignal TransductionCyclic AMP-Dependent Protein KinasesDiazepam Binding Inhibitordiazepam binding inhibitor (33-50)LipidsNeuropeptidesPeptide FragmentsProtein Kinase CRhodaminessulforhodamine 101Type C Phospholipasescholesterolcholesterol precursorsfatty acidsmitochondrianeuronal differentiationoctadecaneuropeptide (ODN), N2a cellsperoxisome

Identifiers

PMID31514417
PMCPMC6767053
OpenAlexW2972723732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.